| 英文名称 |
中文名称 |
CAS号 |
操作 |
| STM2457 |
|
2499663-01-1 |
详细
|
| Batabulin |
Unii-T4np8G3K6q |
195533-53-0 |
详细
|
| MK-8745 |
MK8745 |
885325-71-3 |
详细
|
| S65487 |
S-65487 |
1644600-79-2 |
详细
|
| (S)-Thalidomide |
(-)-沙利度胺 |
841-67-8 |
详细
|
| BAM7 |
|
331244-89-4 |
详细
|
| Devimistat |
6,8-双(苄硫基)辛酸 |
95809-78-2 |
详细
|
| CVT-11127 |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
详细
|
| LCS-1 |
4,5-二氯-2-(3-甲苯基)哒嗪-3-酮 |
41931-13-9 |
详细
|
| BCL6-IN-7 |
化合物 T8731 |
2097518-46-0 |
详细
|
| T-1101 tosylate |
TAI-95 tosylate |
2250404-95-4 |
详细
|
| TVB-3166 |
|
1533438-83-3 |
详细
|
| A-1210477 |
|
1668553-26-1 |
详细
|
| ISRIB (trans-isomer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
详细
|
| Pyridoclax |
|
1651890-44-6 |
详细
|
| ML141 |
ML 141 |
71203-35-5 |
详细
|
| Lisaftoclax |
Bcl-2/Bcl-xl inhibitor 1 |
2180923-05-9 |
详细
|
| CCT369260 |
化合物 CCT369260 |
2647503-57-7 |
详细
|
| SD-36 |
|
2429877-44-9 |
详细
|
| MCL-1/BCL-2-IN-3 |
|
2163793-55-1 |
详细
|
| DCZ0415 |
|
2242470-43-3 |
详细
|
| Cobimetinib |
考比替尼 |
934660-93-2 |
详细
|
| Cantrixil |
|
2135511-22-5 |
详细
|
| SKI-I |
化合物 SKI-I |
306301-68-8 |
详细
|
| FB23-2 |
|
2243736-45-8 |
详细
|
| BCL6-IN-5 |
|
2253878-09-8 |
详细
|
| PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
详细
|
| Maritoclax |
Mcl-1抑制剂 |
1227962-62-0 |
详细
|
| Palomid 529 |
PALOMID 529 (P529) |
914913-88-5 |
详细
|
| Rohinitib |
化合物 ROHINITIB |
1139253-73-8 |
详细
|
| Cilengitide |
西仑吉肽 |
188968-51-6 |
详细
|
| S55746 |
化合物S55746 |
1448584-12-0 |
详细
|
| CLZ-8 |
MCL1-IN-8 |
678158-55-9 |
详细
|
| MPI-0479605 |
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 |
1246529-32-7 |
详细
|
| Desmorpholinyl Navitoclax-NH-Me |
化合物DESMORPHOLINYL NAVITOCLAX-NH-ME |
2365172-82-1 |
详细
|
| APG-1387 |
|
1570231-89-8 |
详细
|
| NSC 15364 |
1,3-二(4-氨基苯基)脲 |
4550-72-5 |
详细
|
| Amiloride hydrochloride |
盐酸阿米洛利 |
2016-88-8 |
详细
|
| Bosutinib hydrate |
博舒替尼一水化合物 |
918639-08-4 |
详细
|
| Nilotinib-d6 |
尼罗替尼-D6 |
1268356-17-7 |
详细
|
| Ponatinib-d8 |
纳替尼-D8 |
1562993-37-6 |
详细
|
| DPH |
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 |
484049-04-9 |
详细
|
| S116836 |
化合物 T24751 |
1257628-57-1 |
详细
|
| GMB-475 |
|
2490599-18-1 |
详细
|
| Rebastinib |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 |
1020172-07-9 |
详细
|
| JX06 |
4,4'-(dithiodicarbonothioyl)dimorpholine |
729-46-4 |
详细
|
| A-1331852 |
|
1430844-80-6 |
详细
|
| Navitoclax-piperazine |
ABT-263-piperazine |
2143096-93-7 |
详细
|
| TCS7010 |
Aurora A Inhibitor I |
1158838-45-9 |
详细
|
| Vincristine-d3-ester (sulfate) |
[2H3]-长春新碱硫酸盐 |
1217854-24-4 |
详细
|
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA |
199807-33-5 |
199807-33-5 |
详细
|
| Olverembatinib |
奥瑞巴替尼布 |
1257628-77-5 |
详细
|
| Olverembatinib dimesylate |
GZD824DIMESYLATE |
1421783-64-3 |
详细
|
| Tributyrin |
三丁酸甘油酯 |
60-01-5 |
详细
|
| Taltobulin |
N,BETA,BETA-三甲基-L-苯基丙氨酰基-N-[(1S,2E)-3-羧基-1-(1-甲基乙基)-2-丁烯基]-N,3-二甲基-L-缬氨酰胺 |
228266-40-8 |
详细
|
| KS106 |
化合物 KS106 |
2408477-50-7 |
详细
|
| ARD-61 |
|
2316837-08-6 |
详细
|
| Z-Asp-CH2-DCB |
CASPASE-1 INHIBITOR V ;Z-VAL-ALA-ASP(OME)-FLUOROMETHYLKETONE |
153088-73-4 |
详细
|
| Takinib |
1111556-37-6 |
1111556-37-6 |
详细
|
| LDN-57444 |
|
668467-91-2 |
详细
|
| Eprenetapopt |
APR-246 |
5291-32-7 |
详细
|
| Mirodenafil dihydrochloride |
米罗那非二盐酸盐 |
862189-96-6 |
详细
|
| Flunisolide |
氟尼缩松 |
3385-03-3 |
详细
|
| ASTX660 |
|
1799328-86-1 |
详细
|
| Ketoprofen-d3 |
酮洛芬D3 |
159490-55-8 |
详细
|
| PDK4-IN-1 hydrochloride |
|
2310262-11-2 |
详细
|
| Mangafodipir trisodium |
锰福地吡三钠 |
140678-14-4 |
详细
|
| BTK inhibitor 10 |
|
2241732-30-7 |
详细
|
| PTC209 HBr |
PTC-209HBR |
1217022-63-3 |
详细
|
| BMS-986142 |
BMS986142 |
1643368-58-4 |
详细
|
| GNF-5 |
|
778277-15-9 |
详细
|
| Btk inhibitor 2 |
|
1558036-85-3 |
详细
|
| Des-Arg9]-Bradykinin acetate |
[DES-ARG9]-缓激肽 乙酸盐 水合物 |
23827-91-0 |
详细
|
| ARQ 531 |
ARQ-531 |
2095393-15-8 |
详细
|
| TL-895 |
2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]- |
1415823-49-2 |
详细
|
| UMI-77 |
|
518303-20-3 |
详细
|
| (±)-Zanubrutinib |
(±)-赞鲁替尼 |
1633350-06-7 |
详细
|
| (E)-Ferulic acid-d3 |
阿魏酸-D3 |
860605-59-0 |
详细
|
| Perphenazine-d4 |
奋乃静D4 |
155593-75-2 |
详细
|
| MM-401 TFA |
化合物 MM-401 TFA |
1442106-11-7 |
详细
|
| 3BDO |
3BDO, MTOR激酶激活剂, 自噬抑制剂 |
890405-51-3 |
详细
|
| Bradykinin (2-9) |
|
16875-11-9 |
详细
|
| BODIPYR6Gcarboxylicacid |
BODIPYR6G羧酸 |
174881-57-3 |
详细
|
| SJF620 |
|
2376187-16-3 |
详细
|
| (R)-Pirtobrutinib |
|
2101700-14-3 |
详细
|
| Lys-[Des-Arg9]Bradykinin TFA |
化合物LYS-[DES-ARG9]BRADYKININ,TFA |
2763588-90-3 |
详细
|
| Dihydrodiol-Ibrutinib |
依鲁替尼代谢物 |
1654820-87-7 |
详细
|
| BDP TMR NHS ester |
BODIPYTMRNHS活化酯 |
485397-12-4 |
详细
|
| Branebrutinib |
BMS-986195 |
1912445-55-6 |
详细
|
| Bradykinin (1-5) |
ARG-PRO-PRO-GLY-PHE |
23815-89-6 |
详细
|
| BODIPYFLcarboxylicacid |
BODIPYFL羧酸 |
165599-63-3 |
详细
|
| BODIPY564/570carboxylicacid |
BODIPY564/570羧酸 |
150173-89-0 |
详细
|
| Bafetinib |
巴氟替尼 |
859212-16-1 |
详细
|
| RRx-001 |
|
925206-65-1 |
详细
|
| BODIPYFLNHSester |
BODIPYFLNHS活化酯 |
146616-66-2 |
详细
|
| Zanubrutinib |
泽布替尼 |
1691249-45-2 |
详细
|
| BODIPY558/568NHSester |
BODIPY558/568NHS活化酯 |
150173-73-2 |
详细
|
| (S)-ML753286 |
1699720-85-8 |
1699720-85-8 |
详细
|
| Asciminib hydrochloride |
阿思尼布盐酸盐 |
2119669-71-3 |
详细
|
| Elacridar |
依克立达 |
143664-11-3 |
详细
|